As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight ... the key ingredient in Eli Lilly’s (LLY) ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

New guidelines for diabetes treatment, mpox research, and healthcare system improvements discussed in comprehensive health ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...